Eye Health Academy - Eye Health Academy

Eye Health Academy Hero

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Popular

Weekly Wear for a Seasonal Shift
Weekly Wear for a Seasonal Shift
Modern Optometry
Weekly Wear for a Seasonal Shift
- Mark E. Schaeffer, OD, FAAO
Combatting the Fall DED Surge
Combatting the Fall DED Surge
Modern Optometry
Combatting the Fall DED Surge
- Mila Ioussifova, OD, CNS, FAAO, FOWNS
EMPOWER - Cornea Health Diagnostic Tools
EMPOWER - Cornea Health Diagnostic Tools
Modern Optometry
EMPOWER - Cornea Health Diagnostic Tools
- Jacob Lang, OD, FAAO
- Paul Hammond, OD, FAAO
- Jason Compton, OD, FAAO
Mapping the Landscape: Diagnostic Tools in Corneal Health
Mapping the Landscape: Diagnostic Tools in Corneal Health
Modern Optometry
Mapping the Landscape: Diagnostic Tools in Corneal Health
- Paul Hammond, OD, FAAO
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Eye on Ocular Health
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
- Lisa Schocket, MD
Strategies for Addressing Complications in Retinal Vein Occlusion
Strategies for Addressing Complications in Retinal Vein Occlusion
Eye on Ocular Health
Strategies for Addressing Complications in Retinal Vein Occlusion
- Lisa Schocket, MD
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Eye on Ocular Health
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
- Houman Hemmati, MD, PhD
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
AAO Action Center
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye

Clinical Practice

Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Eye on Ocular Health
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
- Houman Hemmati, MD, PhD
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
AAO Action Center
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
- Anat Galor, MD
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
AAO Action Center
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
Cleaner Air, Clearer Vision: Uncovering Air Pollution’s Role in Childhood Myopia
Cleaner Air, Clearer Vision: Uncovering Air Pollution’s Role in Childhood Myopia
Eye on Ocular Health
Cleaner Air, Clearer Vision: Uncovering Air Pollution’s Role in Childhood Myopia
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Eye on Ocular Health
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
- Charles Turck, PharmD, BCPS, BCCCP
- Michael Javaheri, MD
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Eye on Ocular Health
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
- Charles Turck, PharmD, BCPS, BCCCP
- Joseph M. Coney, MD
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular Health
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
- Marlene Mimi Maeusli, PhD.
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Eye on Ocular Health
Myopia Control in Europe: The Case for Upfront Investment in Childhood